CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
SUNDAY 04 SEPTEMBER, 2016
Aims : Idiopathic pulmonary fibrosis (IPF) is a progressive disease of unknown aetiology that associates with high mortality. The
treatment options are limited. The two most common comorbidities that associate with IPF are emphysema and pulmonary hypertension
(PH). Both worsen the prognosis of IPF. The prevalence of combined pulmonary fibrosis and emphysema (CPFE) may be as high as 35%
(Cottin 2013). PH in IPF has not been extensively studied but its reported incidence ranges from 32% to 84% (Lettieri et al., 2006 and
Nadrous et al., 2005). These comorbidites in IPF are a major challenge for both physicians and scientists. The treatment options are
limited, largely because of the lack of understanding of the underlying pathophysiology. Moreover, clinical guidelines that recommend
how to treat these comorbidities in IPF are lacking. A session where the perspectives of scientists and physicians on comorbidities in IPF
can be discussed has not been organised previously. We hope that the present session will further our understanding of the pathogenetic
pathways that underlie the deleterious effects of comorbidities in IPF and will help to optimise the management of patients with IPF and
comorbidities.
Tag(s) : Translational
Target audience : Clinician, Fellow, General practitioner, Junior member, Occupational therapist, Patient, Pulmonologist, Researcher,
Resident, Respiratory physician, Scientist, Trainee
Chairs : Christian M. Kähler (Wangen im Allgäu, Germany), Athol Wells (London, United Kingdom)
14:45
15:15
15:45
The celullar and molecular basis
Oliver Eickelberg (Munich, Germany)
Genetic and environmental factors of IPF
Ivana V. Yang (Denver, United States of America)
Emphysema in IPF
Vincent Cottin (Lyon, France)
1475
1476
1477
16:15
Pulmonary hypertension and IPF
Soni Savai Pullamsetti (Bad Nauheim, Germany)
Platinum Room 3+4 Session 241 14:45 - 16:45
Oral Presentation: Molecular pathways of smoking-induced diseases
Chairs : Ian M. Adcock (London, United Kingdom), Hiroo Wada (Tokyo, Japan)
1478
OA1479
OA1480
OA1481
OA1482
OA1483
OA1484
OA1485
OA1486
LATE-BREAKING ABSTRACT: Activity limitation and exacerbations in smokers with emphysema on CT but
preserved pulmonary function. SPIROMICS
Christian Lo Cascio (New York, United States of America), Christian Lo Cascio, Eugene Bleecker, Stephanie Christenson,
David Couper, Jeffrey Curtis, Nadia Hansel, Eric Hoffman, Richard Kaner, Eric Kleerup, Stephen Lazarus, Fernando
Martinez, Robert Paine, Stephen Rennard, Russ Bowler, Jerry Krishnan, Mark Dransfield, Alejandro Comellas, Donald
Tashkin, MeiLan Han, Prescott Woodruff, R. Graham Barr
Reduced phagocytic capacity of blood monocyte/macrophages in tuberculosis patients is further reduced by smoking
Esmaeil Mortaz (Utrecht, Netherlands), Mahshid Aryanpur, Esmaeil Mortaz, Mohammad Reza MasjedI, Seyed Mohammad
Reza Aryan, Payam Tabarsi, Johan Garssen, Ian M. Adcock
Cigarette smoking in patients newly-diagnosed with pulmonary tuberculosis
Mahshid Aryanpur (Tehran, Islamic Republic of Iran), Mahshid Aryanpur, Mohammad Reza Masjedi, Esmaeil Mortaz,
Zahra Hessami, Mohammad Reza Aryan, Gholamreza Heydari, Mostafa Hossei, Hooman Sharifi, Masoud Baikpour, Payam
Tabarsi
Relationship between cigarette (nicotine) addiction and dopamine receptor D2 gene variants (TaqlA and -141C Ins/
Del)
Mehmet Atilla Uysal (?STANBUL, Turkey), Ulgen Sever, Mehmet Atilla Uysal, Yedikule Smoking Cessation Study
Group, Sacide Pehlivan
The neurogenic inflammation markers in rat’s brain in experimental smoking
Vera Nevzorova (Vladivostok, Primorsky Krai, Russian Federation), Vera Nevzorova, Natalia Zakharchuk, Elena Gonchar
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and
healthy smokers
Marta Maskey-Warzechowska (Warsaw, Poland), Marta Maskey-Warzechowska, Patrycja Nejman-Gryz, Katarzyna Osinka,
Paulina Lis, Kamila Malesa, Katarzyna Gorska, Rafal Krenke
Analysis of CYP2A6 and CYP2A13 genes using new generation sequencing method in smokers and non-smokers.
Mehmet Atilla Uysal (?STANBUL, Turkey), Sacide Pehlivan, Mehmet Atilla Uysal, Tülin Çagatay, Cigdem Keklik Cinar,
Feyza Erkan, Ulgen Sever, Zuleyha Bingol, Mustafa Pehlivan, Yedikule Smoking Cessation Study Group, Sadrettin Pençe
The dopamine receptor D4 VNTR 48bp gene variant in nicotine addiction
Mehmet Atilla Uysal (?STANBUL, Turkey), Mehmet Atilla Uysal, Ulgen Sever, Smoking Cessation Study Group, Sacide
Pehlivan
103 26.08.2016